Popovic Djordje S,Papachristou Stella,Papanas Nikolaos (2025) Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 Diabetes, CURRENT VASCULAR PHARMACOLOGY, vol. , br. , str. - (Editorial Material; Early Access) 

Papachristou Stella,Popovic Djordje S,Papanas Nikolaos (2023) Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk, INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, vol. 43, br. 5, str. 779-780 (Letter) 

Popovic Djordje S,Papachristou Stella,Stokic Edita J,Papanas Nikolaos (2022) Ezetimibe and Insulin Resistance, CURRENT VASCULAR PHARMACOLOGY, vol. 20, br. 4, str. 315-317 (Editorial Material) 

Papachristou Stella,Popovic Djordje S,Papanas Nikolaos (2022) Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?, ADVANCES IN THERAPY, vol. 39, br. 6, str. 2283-2286 (Editorial Material) 

Papachristou Stella,Popovic Djordje S,Papanas Nikolaos (2021) The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?, DIABETES-METABOLISM RESEARCH AND REVIEWS, vol. 37, br. 8, str. - (Editorial Material)